Advertisement
CLSK vs PHR
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLSK is a StrongBuy and PHR is a Buy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CLSK’s FA Score shows that 1 FA rating(s) are green whilePHR’s FA Score has 0 green FA rating(s).
- CLSK’s FA Score: 1 green, 4 red.
- PHR’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CLSK’s TA Score shows that 5 TA indicator(s) are bullish while PHR’s TA Score has 4 bullish TA indicator(s).
- CLSK’s TA Score: 5 bullish, 5 bearish.
- PHR’s TA Score: 4 bullish, 5 bearish.
Price Growth
CLSK (@Investment Banks/Brokers) experienced а +8.22% price change this week, while PHR (@Services to the Health Industry) price change was -4.81% for the same time period.
The average weekly price growth across all stocks in the @Investment Banks/Brokers industry was -1.37%. For the same industry, the average monthly price growth was +13.63%, and the average quarterly price growth was +66.91%.
The average weekly price growth across all stocks in the @Services to the Health Industry industry was +2.27%. For the same industry, the average monthly price growth was +5.18%, and the average quarterly price growth was +24.49%.
Reported Earning Dates
CLSK is expected to report earnings on Dec 17, 2025.
PHR is expected to report earnings on Dec 15, 2025.
Industries' Descriptions
@Investment Banks/Brokers (-1.37% weekly)These banks specialize in underwriting (helping companies with debt financing or equity issuances), IPOs, facilitating mergers and other corporate reorganizations and acting as a broker or financial advisor for institutions. They might also trade securities on their own accounts. Investment banks potentially thrive on expanding its network of clients, since that could help them increase profits. Goldman Sachs, Morgan Stanley and CME Group Inc are some of the largest investment banking companies.
@Services to the Health Industry (+2.27% weekly)This industry comprises companies that provide services, such as equipment sterilization, research, physician management systems and consulting, that support the healthcare/medical industry. Examples of such companies include Laboratory Corporation of America Holdings, which operates one of the largest clinical laboratory networks in the world; Quest Diagnostics Inc., which is a clinical laboratory; and Syneos Health, which is a major clinical research organization.
| CLSK | PHR | CLSK / PHR | |
| Capitalization | 3.64B | 1.42B | 257% |
| EBITDA | 626M | 7.13M | 8,780% |
| Gain YTD | 61.455 | -6.399 | -960% |
| P/E Ratio | 17.29 | N/A | - |
| Revenue | 632M | 450M | 140% |
| Total Cash | 916M | 98.3M | 932% |
| Total Debt | 820M | 12.8M | 6,406% |
CLSK | PHR | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 41 | 56 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 73 Overvalued | 41 Fair valued | |
PROFIT vs RISK RATING 1..100 | 91 | 100 | |
SMR RATING 1..100 | 51 | 94 | |
PRICE GROWTH RATING 1..100 | 38 | 65 | |
P/E GROWTH RATING 1..100 | 22 | 100 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
PHR's Valuation (41) in the null industry is in the same range as CLSK (73). This means that PHR’s stock grew similarly to CLSK’s over the last 12 months.
CLSK's Profit vs Risk Rating (91) in the null industry is in the same range as PHR (100). This means that CLSK’s stock grew similarly to PHR’s over the last 12 months.
CLSK's SMR Rating (51) in the null industry is somewhat better than the same rating for PHR (94). This means that CLSK’s stock grew somewhat faster than PHR’s over the last 12 months.
CLSK's Price Growth Rating (38) in the null industry is in the same range as PHR (65). This means that CLSK’s stock grew similarly to PHR’s over the last 12 months.
CLSK's P/E Growth Rating (22) in the null industry is significantly better than the same rating for PHR (100). This means that CLSK’s stock grew significantly faster than PHR’s over the last 12 months.
| CLSK | PHR | |
|---|---|---|
| RSI ODDS (%) | 4 days ago 90% | 4 days ago 77% |
| Stochastic ODDS (%) | 4 days ago 83% | 4 days ago 79% |
| Momentum ODDS (%) | 4 days ago 90% | 4 days ago 84% |
| MACD ODDS (%) | 4 days ago 90% | 4 days ago 77% |
| TrendWeek ODDS (%) | 4 days ago 89% | 4 days ago 82% |
| TrendMonth ODDS (%) | 4 days ago 87% | 4 days ago 84% |
| Advances ODDS (%) | 6 days ago 87% | N/A |
| Declines ODDS (%) | 4 days ago 89% | 5 days ago 81% |
| BollingerBands ODDS (%) | 4 days ago 82% | 4 days ago 77% |
| Aroon ODDS (%) | 4 days ago 86% | 4 days ago 85% |
Advertisement